1. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Shrestha, A.; Penrod, J.R.; Reck, M.; Spigel, D.R.; Smiechowski, B.; Bognar, K.; Van Eijndhoven, E.; Makris, C.; Healey, D.; Hertel, N.; Korytowsky, B.; Cope, S.; Vanderpuye-Orgle, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Eberhardt, W.E.E.; Vanderpuye-Orgle, J.; Reck, M.; Waterhouse, D.; Smiechowski, B.; Bognar, K.; Van Eijndhoven, E.; Makris, C.; Blackwood-Chirchir, A.; Hertel, N.; Korytowsky, B.; Cope, S.; Penrod, J.R.; Shrestha, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach. (February 2017) Authors: Thornton Snider, J.; Sexton Ward, A.; Penrod, J.R.; Dastani, H.; Yuan, Y.; Van Eijndhoven, E.; Figlin, R.A.; Chandra, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗